The Current Ratio as of December 2025 (TTM) for Iterum Therapeutics plc (ITRM) is 2.13

According to Iterum Therapeutics plc’s latest financial reports and current stock price. The company's current Current Ratio is 2.13. This represents a change of -14.25% compared to the average of 2.49 of the last 4 quarters.

Iterum Therapeutics plc (ITRM) Historical Current Ratio (quarterly & annually)

How has ITRM Current Ratio performed in the past?

The mean historical Current Ratio of Iterum Therapeutics plc over the last ten years is 4.06. The current 2.13 Current Ratio has changed 5.16% with respect to the historical average. Over the past ten years (40 quarters), ITRM's Current Ratio was at its highest in in the September 2018 quarter at 14.05. The Current Ratio was at its lowest in in the March 2017 quarter at 0.

Iterum Therapeutics plc (ITRM) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Iterum Therapeutics plc Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Iterum Therapeutics plc (ITRM) Average Current Ratio

How has ITRM Current Ratio performed in the past?

The current Current Ratio of Iterum Therapeutics plc (ITRM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Iterum Therapeutics plc (ITRM) Current Ratio vs. Peers

How is ITRM’s Current Ratio compared to its peers?

Iterum Therapeutics plc’s Current Ratio is less than Intensity Therapeutics, Inc. (3.60), less than iBio, Inc. (8.39), less than Rallybio Corporation (9.98), less than Pluri Inc. (4.81), less than AN2 Therapeutics, Inc. (31.96), less than Boundless Bio, Inc. (14.08), greater than Sonnet BioTherapeutics Holdings, Inc. (0.26), less than TAO Synergies Inc. (20.51), less than Q32 Bio Inc. (4.57), less than Klotho Neurosciences, Inc. (83.69),

Build a custom stock screener for Iterum Therapeutics plc (ITRM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Iterum Therapeutics plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Iterum Therapeutics plc (ITRM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Iterum Therapeutics plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.